
Nazara Technologies Gears Up for Q3 Reveal on 3rd February; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 2 Feb 2026 • 7:59 pm
Posted by:

Nazara Technologies's Q3 results FY26 are scheduled to be announced on 3rd February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Nazara Technologies Q3 Results 2026 Preview
- Nazara Technologies's revenue is expected to be in the range of ₹30.68 crore, a 39.64% YoY increase.
- Profit After Tax, or PAT, is projected to rise 39.64% YoY.
- Net profit is ₹30.68 crore, up 39.64% YoY
- EBITDA to fall 0.00%
Nazara Technologies Share Performance
- Over the past six months, Nazara Technologies's share price has fallen by 10.40% to ₹922.00.
- Moreover, over the past year, the stock has decreased by 89.03%.
- Despite this weak short-term performance, Nazara Technologies's stock has delivered a financially sound 681.69% return over the past 5 years.
- As of 3rd February 2026, the stock traded at ₹922.00 per share.
Key Factors to Watch for Nazara Technologies Q3 Results FY26
- Profitability & Margins: Watch EBITDA and net profit margins to see if cost pressures (like field force and regulatory impacts) are affecting profitability.
- Export & Speciality Segment Performance: Performance in exports and high‑margin speciality/chronic segments (including products from the Bharat Serums & Vaccines integration) will be key for growth and margin support.
- New Product Approvals & R&D Impact: Updates on new launches, R&D progression, and regulatory approvals (especially for chronic, OTC, and speciality drugs) could drive future revenue momentum.
- Cost & Working Capital Trends: Trends in operating costs, field force efficiency, and working capital optimisation will reveal financial discipline and cash flow strength.
Final Thoughts
Nazara Technologies will announce its Q3 FY26 results on 2nd February 2026. Analysts expect 9.% YoY1.02% revenue growth, a 4.46% fall in PAT, and a 9.17% fall in EBITDA.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Recent Articles

CARE Ratings Q1 FY27 Results: Revenue Rs 111 Cr, PAT Rs 32 Cr and Key Highlights
10 August 2026

Goldiam International Q1 FY27 Results: Revenue Rs 326 Cr, PAT Rs 73 Cr and Key Highlights
10 August 2026

Powerica Q1 FY27 Results: Revenue Rs 780 Cr, PAT Rs 64 Cr and Key Highlights
10 August 2026

Mrs. Bectors Food Q1 FY27 Results: Revenue Rs 548 Cr, PAT Rs 38 Cr and Key Highlights
10 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
CARE Ratings Q1 FY27 Results: Revenue Rs 111 Cr, PAT Rs 32 Cr and Key Highlights
Goldiam International Q1 FY27 Results: Revenue Rs 326 Cr, PAT Rs 73 Cr and Key Highlights
Powerica Q1 FY27 Results: Revenue Rs 780 Cr, PAT Rs 64 Cr and Key Highlights
Mrs. Bectors Food Q1 FY27 Results: Revenue Rs 548 Cr, PAT Rs 38 Cr and Key Highlights
Dynamatic Technologies Q1 FY27 Results: Revenue Rs 424 Cr, PAT Rs 20 Cr and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





